Regulation of cartilage formation and maturation by mitogen-activated protein kinase signaling

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 84, Issue 2, 2008, Pages 131-154

  Bobick, Brent E ^a   Kulyk, William M ^b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Cartilage differentiation; Chondrogenesis; Endochondral ossification; ERK; Mitogen activated protein kinase (MAPK); P38

Indexed keywords

A RAF KINASE; ACTIVATING TRANSCRIPTION FACTOR 2; B RAF KINASE; BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; LYMPHOID ENHANCER FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; RAF PROTEIN; RAP1 PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR MSX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX6; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNINDEXED DRUG;

APOPTOSIS; BONE MATRIX; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL SPECIFICITY; CHONDROGENESIS; DEVELOPMENTAL STAGE; EMBRYO DEVELOPMENT; ENCHONDRAL OSSIFICATION; HYALINE CARTILAGE; HYPERTROPHY; MESENCHYMAL STEM CELL; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VERTEBRATE;

ANIMALS; CARTILAGE; CELL DIFFERENTIATION; CHONDROGENESIS; FACE; HOMEOSTASIS; HUMANS; HYPERTROPHY; LIMB BUDS; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OSSIFICATION, HETEROTOPIC; OSTEOGENESIS; PHOSPHORIC MONOESTER HYDROLASES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

VERTEBRATA;

EID: 46849098011     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.20126     Document Type: Review

References (161)

1. Abell AN, Rivera-Perez JA, Cuevas BD, et al. 2005. Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo. Mol Cell Biol 25:8948-8959.
2. Adachi M, Fukuda M, Nishida E. 1999. Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J 18:5347-5358.
3. Agoston H, Khan S, James CG, et al. 2007. C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways. BMC Dev Biol 7:18.
4. Akiba E, Yonei-Tamura S, Yajima H, et al. 2001. Fibroblast growth factor-induced gene expression and cartilage pattern formation in chick limb bud recombinants. Dev Growth Differ 43:165-175.
5. Atsumi T, Miwa Y, Kimata K, Ikawa Y. 1990. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev 30:109-116.
6. Baksh D, Song L, Tuan RS. 2004. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301-316.
7. Barnard JC, Williams AJ, Rabier B, et al. 2005. Thyroid hormones regulate fibroblast growth factor receptor signaling during chondrogenesis. Endocrinology 146:5568-5580.
8. Barnes GL, Alexander PG, Hsu CW, Mariani BD, Tuan RS. 1997. Cloning and characterization of chicken Paraxis: a regulator of paraxial mesoderm development and somite segmentation. Dev Biol 189:95-111.
9. Bastow ER, Lamb KJ, Lewthwaite JC, et al. 2005. Selective activation of the MEK-ERK pathway is regulated by mechanical stimuli in forming joints and promotes pericellular matrix formation. J Biol Chem 280:11749-11758.
10. Beier F, Taylor AC, LuValle P. 1999. Raf signaling stimulates and represses the human collagen type X promoter through distinguishable elements. J Cell Biochem 72:549-557.
11. Ben-Eliezer M, Phillip M, Gat-Yablonski G. 2007. Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways. Endocrine 32:235-244.
12. Ben-Levy R, Hooper S, Wilson R, et al. 1998. Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2. Curr Biol 8:1049-1057.
13. Bi W, Deng JM, Zhang Z, et al. 1999. Sox9 is required for cartilage formation. Nat Genet 22:85-89.
14. Bi W, Huang W, Whitworth DJ, et al. 2001. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98:6698-6703.
15. Bloom MW, Murakami S, Cody D, et al. 2006. Aspects of achondroplasia in the skulls of dwarf transgenic mice: a cephalometric study. Anat Rec A Discov Mol Cell Evol Biol 288:316-322.
16. Bobick BE, Kulyk WM. 2004. The MEK-ERK signaling pathway is a negative regulator of cartilage-specific gene expression in embryonic limb mesenchyme. J Biol Chem 279:4588-4595.
17. Bobick BE, Kulyk WM. 2006. MEK-ERK signaling plays diverse roles in the regulation of facial chondrogenesis. Exp Cell Res 312:1079-1092.
18. Bobick BE, Thornhill TM, Kulyk WM. 2007. Fibroblast growth factors 2, 4, and 8 exert both negative and positive effects on limb, frontonasal, and mandibular chondrogenesis via MEK-ERK activation. J Cell Physiol 211:233-243.
19. Cancedda R, Castagnola P, Cancedda FD, et al. 2000. Developmental control of chondrogenesis and osteogenesis. Int J Dev Biol 44:707-714.
20. Carlson MR, Bryant SV, Gardiner DM. 1998. Expression of Msx-2 during development, regeneration, and wound healing in axolotl limbs. J Exp Zool 282:715-723.
21. Carrington JL, Chen P, Yanagishita M, Reddi AH. 1991. Osteogenin (bone morphogenetic protein-3) stimulates cartilage formation by chick limb bud cells in vitro. Dev Biol 146:406-415.
22. Chang SH, Oh CD, Yang MS, et al. 1998. Protein kinase C regulates chondrogenesis of mesenchymes via mitogen-activated protein kinase signaling. J Biol Chem 273:19213-19219.
23. Chang F, Steelman LS, Shelton JG, et al. 2003. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). Int J Oncol 22:469-480.
24. Chen FH, Rousche KT, Tuan RS. 2006. Technology insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2:373-382.
25. Chen JK, Shapiro HS, Wrana JL, et al. 1991. Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization. Matrix 11:133-143.
26. Chen P, Carrington JL, Paralkar VM, et al. 1992. Chick limb bud mesodermal cell chondrogenesis: inhibition by isoforms of platelet-derived growth factor and reversal by recombinant bone morphogenetic protein. Exp Cell Res 200:110-117.
27. Ciarmatori S, Kiepe D, Haarmann A, et al. 2007. Signaling mechanisms leading to regulation of proliferation and differentiation of the mesenchymal chondrogenic cell line RCJ3.1C5.18 in response to IGF-I. J Mol Endocrinol 38:493-508.
28. Corson LB, Yamanaka Y, Lai KM, Rossant J. 2003. Spatial and temporal patterns of ERK signaling during mouse embryogenesis. Development 130:4527-4537.
29. Crawford HC, Matrisian LM. 1996. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49:20-37.
30. Davidson D, Blanc A, Filion D, et al. 2005. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem 280:20509-20515.
31. De Croos JN, Dhaliwal SS, Grynpas MD, et al. 2006. Cyclic compressive mechanical stimulation induces sequential catabolic and anabolic gene changes in chondrocytes resulting in increased extracellular matrix accumulation. Matrix Biol 25:323-331.
32. Delfini MC, Dubrulle J, Malapert P, et al. 2005. Control of the segmentation process by graded MAPK/ERK activation in the chick embryo. Proc Natl Acad Sci USA 102:11343-11348.
33. DeLise AM, Fischer L, Tuan RS. 2000. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 8:309-334.
34. DeLise AM, Tuan RS. 2002. Alterations in the spatiotemporal expression pattern and function of N-cadherin inhibit cellular condensation and chondrogenesis of limb mesenchymal cells in vitro. J Cell Biochem 87:342-359.
35. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425:577-584.
36. Dougherty MK, Muller J, Ritt DA, et al. 2005. Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell 17:215-224.
37. Eblaghie MC, Lunn JS, Dickinson RJ, et al. 2003. Negative feedback regulation of FGF signaling levels by Pyst1/MKP3 in chick embryos. Curr Biol 13:1009-1018.
38. Fanning PJ, Emkey G, Smith RJ, et al. 2003. Mechanical regulation of mitogen-activated protein kinase signaling in articular cartilage. J Biol Chem 278:50940-50948.
39. Fischer L, Boland G, Tuan RS. 2002. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem 84:816-831.
40. Ganiatsas S, Kwee L, Fujiwara Y, et al. 1998. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis. Proc Natl Acad Sci USA 95:6881-6886.
41. Ge B, Gram H, Di Padova F, et al. 2002. MAPKK-independent activation of p38α mediated by TAB1-dependent autophosphorylation of p38α. Science 295:1291-1294.
42. Geduspan JS, Solursh M. 1993. Effects of the mesonephros and insulin-like growth factor I on chondrogenesis of limb explants. Dev Biol 156:500-508.
43. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285:1028-1032.
44. Guha U, Gomes WA, Kobayashi T, et al. 2002. In vivo evidence that BMP signaling is necessary for apoptosis in the mouse limb. Dev Biol 249:108-120.
45. Hatakeyama Y, Nguyen J, Wang X, et al. 2003. Smad signaling in mesenchymal and chondroprogenitor cells. J Bone Joint Surg Am A 85(Suppl 3):13-18.
46. Hilger RA, Scheulen ME, Strumberg D. 2002. The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie 25:511-518.
47. Hirao M, Tamai N, Tsumaki N, et al. 2006. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 281:31079-31092.
48. Hoffman LM, Weston AD, Underhill TM. 2003. Molecular mechanisms regulating chondroblast differentiation. J Bone Joint Surg Am A 85(Suppl 2):124-132.
49. Horton WE Jr, Cleveland J, Rapp U, et al. 1988. An established rat cell line expressing chondrocyte properties. Exp Cell Res 178:457-468.
50. Huang Z, Xu H, Sandell L. 2004. Negative regulation of chondrocyte differentiation by transcription factor AP2α. J Bone Miner Res 19:245-255.
51. Hutchison M, Berman KS, Cobb MH. 1998. Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades. J Biol Chem 273:28625-28632.
52. Ikeda K, Takayama T, Suzuki N, et al. 2006. Effects of low-intensity pulsed ultrasound on the differentiation of C2C12 cells. Life Sci 79:1936-1943.
53. Ito Y, Bringas P Jr, Mogharei A, et al. 2002. Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor β-mediated Meckel's cartilage development. Dev Dyn 224:69-78.
54. Jin EJ, Choi YA, Kyun Park E, et al. 2007. MMP-2 functions as a negative regulator of chondrogenic cell condensation via down-regulation of the FAK-integrin beta1 interaction. Dev Biol 308:474-484.
55. Jin EJ, Lee SY, Choi YA, et al. 2006a. BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated downregulation of Wnt-7a pathway. Mol Cell 22:353-359.
56. Jin EJ, Park JH, Lee SY, et al. 2006b. Wnt-5a is involved in TGF-β3-stimulated chondrogenic differentiation of chick wing bud mesenchymal cells. Int J Biochem Cell Biol 38:183-195.
57. Johnson GL, Lapadat R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912.
58. Kawakami Y, Rodriguez-Leon J, Koth CM, et al. 2003. MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat Cell Biol 5:513-519.
59. Keyse SM. 2008. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev 27:253-261.
60. Kinkel MD, Horton WE Jr. 2003. Coordinate down-regulation of cartilage matrix gene expression in Bcl-2 deficient chondrocytes is associated with decreased SOX9 expression and decreased mRNA stability. J Cell Biochem 88:941-953.
61. Kitamura H, Okazaki M. 2005. AG-041R, a novel indoline-2-one derivative, stimulates chondrogenesis in a bipotent chondroprogenitor cell line CL-1. Osteoarthritis Cartilage 13:287-296.
62. Kolch W. 2005. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6:827-837.
63. Kondoh K, Nishida E. 2007. Regulation of MAP kinases by MAP kinase phosphatases. Biochim Biophys Acta 1773:1227-1237.
64. Krejci P, Bryja V, Pachernik J, et al. 2004. FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp Cell Res 297:152-164.
65. Krejci P, Masri B, Fontaine V, et al. 2005. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci 118(Pt21):5089-5100.
66. Kronenberg HM. 2003. Developmental regulation of the growth plate. Nature 423:332-336.
67. Kuang D, Zhao X, Xiao G, et al. 2007. Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK. Basic Res Cardiol 103:265-273.
68. Kulyk WM, Franklin JL, Hoffman LM. 2000. Sox9 expression during chondrogenesis in micromass cultures of embryonic limb mesenchyme. Exp Cell Res 255:327-332.
69. Kulyk WM, Reichert C. 1992. Staurosporine, a protein kinase inhibitor, stimulates cartilage differentiation by embryonic facial mesenchyme. J Craniofac Genet Dev Biol 12:90-97.
70. Kulyk WM, Rodgers BJ, Greer K, Kosher RA. 1989. Promotion of embryonic chick limb cartilage differentiation by transforming growth factor-β. Dev Biol 135:424-430.
71. Kyriakis JM, Avruch J. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81:807-869.
72. Lazarus JE, Hegde A, Andrade AC, et al. 2007. Fibroblast growth factor expression in the postnatal growth plate. Bone 40:577-586.
73. Lee JW, Kim YH, Kim SH, et al. 2004. Chondrogenic differentiation of mesenchymal stem cells and its clinical applications. Yonsei Med J 45(Suppl):41-47.
74. Lefebvre V, Behringer RR, de Crombrugghe B. 2001. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartil 9(Suppl A):S69-S75.
75. Lefebvre V, Garofalo S, de Crombrugghe B. 1995. Collagen type X gene expression in mouse chondrocytes immortalized by a temperature-sensitive simian virus 40 large tumor antigen. J Cell Biol 128:239-245.
76. Lewthwaite JC, Bastow ER, Lamb KJ, et al. 2006. A specific mechanomodulatory role for p38 MAPK in embryonic joint articular surface cell MEK-ERK pathway regulation. J Biol Chem 281:11011-11018.
77. Li C, Scott DA, Hatch E, et al. 2007. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development 134:167-176.
78. Lim YB, Kang SS, An WG, et al. 2003. Chondrogenesis induced by actin cytoskeleton disruption is regulated via protein kinase C-dependent p38 mitogen-activated protein kinase signaling. J Cell Biochem 88:713-718.
79. Liu Z, Xu J, Colvin JS, Ornitz DM. 2002. Coordination of chondrogenesis and osteogenesis by fibroblast: growth factor 18. Genes Dev 16:859-869.
80. Longobardi L, O'Rear L, Aakula S, et al. 2006. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-β signaling. J Bone Miner Res 21:626-636.
81. Lunn JS, Fishwick KJ, Halley PA, Storey KG. 2007. A spatial and temporal map of FGF/Erk1/2 activity and response repertoires in the early chick embryo. Dev Biol 302:536-552.
82. Macias D, Ganan Y, Sampath TK, et al. 1997. Role of BMP-2 and OP-1 (BMP7) in programmed cell death and skeletogenesis during chick limb development. Development 124:1109-1117.
83. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
84. Martin-Blanco E. 2000. p38 MAPK signalling cascades: ancient roles and new functions. Bioessays 22:637-645.
85. Mayne R, Ala-Kokko L. 2005. Collagen structure and function. In: Koopman WJ, Moreland LW, editors. Arthritis and Allied Conditions: A Textbook of Rheumatology. 15th ed. Philadelphia, PA: Lippincott Williams & Wilkins. pp. 189-209.
86. McMahon LA, Prendergast PJ, Campbell VA. 2008. A comparison of the involvement of p38, ERK1/2, and PI3K in growth factor-induced chondrogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 368:990-995.
87. Merino R, Ganan Y, Macias D, et al. 1999. Bone morphogenetic proteins regulate interdigital cell death in the avian embryo. Ann NY Acad Sci 887:120-132.
88. Moftah MZ, Downie SA, Bronstein NB, et al. 2002. Ectodermal FGFs induce perinodular inhibition of limb chondrogenesis in vitro and in vivo via FGF receptor 2. Dev Biol 249:270-282.
89. Moro T, Ogasawara T, Chikuda H, et al. 2005. Inhibition of Cdk6 expression through p38 MAP kinase is involved in differentiation of mouse prechondrocyte ATDC5. J Cell Physiol 204:927-933.
90. Motomura H, Niimi H, Sugimori K, et al. 2007. Gas6, a new regulator of chondrogenic differentiation from mesenchymal cells. Biochem Biophys Res Commun 357:997-1003.
91. Mukhopadhyay K, Lefebvre V, Zhou G, et al. 1995. Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-α 1(11) collagen gene. J Biol Chem 270:27711-27719.
92. Murakami S, Balmes G, McKinney S, et al. 2004. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev 18:290-305.
93. Murakami S, Kan M, McKeehan WL, de Crombrugghe B. 2000. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 97:1113-1118.
94. Nakajima M, Negishi Y, Tanaka H, Kawashima K. 2004. p21(Cip-1/SDI-1/WAF- 1) expression via the mitogen-activated protein kinase signaling pathway in insulin-induced chondrogenic differentiation of ATDC5 cells. Biochem Biophys Res Commun 320:1069-1075.
95. Nakamura K, Shirai T, Morishita S, et al. 1999. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp Cell Res 250:351-363.
96. Naor Z, Benard O, Seger R. 2000. Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab 11:91-99.
97. Naski MC, Ornitz DM. 1998. FGF signaling in skeletal development. Front Biosci 3:d781-d794.
98. Negishi Y, Ui N, Nakajima M, et al. 2001. p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro. J Biol Chem 276:33249-33256.
99. Niswander L. 2002. Interplay between the molecular signals that control vertebrate limb development. Int J Dev Biol 46:877-881.
100. Oh CD, Chang SH, Yoon YM, et al. 2000. Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J Biol Chem 275:5613-5619.
101. Oh CD, Chun JS. 2003. Signaling mechanisms leading to the regulation of differentiation and apoptosis of articular chondrocytes by insulin-like growth factor-1. J Biol Chem 278:36563-36571.
102. Ohuchi H, Nakagawa T, Itoh N, Noji S. 1999. FGF10 can induce Fgf8 expression concomitantly with En1 and R-fng expression in chick limb ectoderm, independent of its dorsoventral specification. Dev Growth Differ 41:665-673.
103. Olsen BR, Reginato AM, Wang W. 2000. Bone development. Annu Rev Cell Dev Biol 16:191-220.
104. Owens DM, Keyse SM. 2007. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26:3203-3213.
105. Ozasa A, Komatsu Y, Yasoda A, et al. 2005. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. Bone 36:1056-1064.
106. Papachristou DJ, Pirttiniemi P, Kantomaa T, et al. 2005. JNK/ERK-AP-1/Runx2 induction "paves the way" to cartilage load-ignited chondroblastic differentiation. Histochem Cell Biol 124:215-223.
107. Paul S, Nairn AC, Wang P, Lombroso PJ. 2003. NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat Neurosci 6:34-42.
108. Phornphutkul C, Wu KY, Gruppuso PA. 2006. The role of insulin in chondrogenesis. Mol Cell Endocrinol 249:107-115.
109. Phornphutkul C, Wu KY, Yang X, et al. 2004. Insulin-like growth factor-I signaling is modified during chondrocyte differentiation. J Endocrinol 183:477-486.
110. Pizette S, Niswander L. 2000. BMPs are required at two steps of limb chondrogenesis: formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev Biol 219:237-249.
111. Poole AR. 2005. Cartilage in health and disease. In: Koopman WJ, Moreland LW, editors. Arthritis and Allied Conditions: A Textbook of Rheumatology.15th ed. Philadelphia, PA: Lippincott Williams & Wilkins. pp. 223-269.
112. Poole AR, Pidoux I, Reiner A, et al. 1984. Association of an extracellular protein (chondrocalcin) with the calcification of cartilage in endochondral bone formation. J Cell Biol 98:54-65.
113. Provot S, Nachtrab G, Paruch J, et al. 2008. A-raf and B-raf are dispensable for normal endochondral bone development, and parathyroid hormone-related peptide suppresses extracellular signal-regulated kinase activation in hypertrophic chondrocytes. Mol Cell Biol 28:344-357.
114. Raingeaud J, Gupta S, Rogers JS, et al. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420-7426.
115. Raman M, Chen W, Cobb MH. 2007. Differential regulation and properties of MAPKs. Oncogene 26:3100-3112.
116. Rane SG. 1999. Ion channels as physiological effectors for growth factor receptor and Ras/ERK signaling pathways. Adv Second Messenger Phosphoprotein Res 33:107-127.
117. Regnier CH, Masson R, Kedinger V, et al. 2002. Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice. Proc Natl Acad Sci USA 99:5585-5590.
118. Ross MH, Kaye GI, Pawlina W. 2003a. Bone. Histology: a text and atlas with cell and molecular biology.4th ed. Philadelphia, PA: Lippincott Williams & Wilkins. pp. 180-213.
119. Ross MH, Kaye GI, Pawlina W. 2003b. Cartilage. Histology: a text and atlas with cell and molecular biology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins. pp. 164-179.
120. Roux PP, Blenis J. 2004. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320-344.
121. Saxena M, Mustelin T. 2000. Extracellular signals and scores of phosphatases: all roads lead to MAP kinase. Semin Immunol 12:387-396.
122. Schlessinger J, Bar-Sagi D. 1994. Activation of Ras and other signaling pathways by receptor tyrosine kinases. Cold Spring Harb Symp Quant Biol 59:173-179.
123. Schneider RA, Hu D, Helms JA. 1999. From head to toe: conservation of molecular signals regulating limb and craniofacial morphogenesis. Cell Tissue Res 296:103-109.
124. Seghatoleslami MR, Roman-Bias JA, Rainville AM, et al. 2003. Progression of chondrogenesis in C3H10T1/2 cells is associated with prolonged and tight regulation of ERK1/2. J Cell Biochem 88:1129-1144.
125. Shapiro IM, Adams CS, Freeman T, Srinivas V. 2005. Fate of the hypertrophic chondrocyte: microenvironmental perspectives on apoptosis and survival in the epiphyseal growth plate. Birth Defects Res C Embryo Today 75:330-339.
126. Shi Y, Gaestel M. 2002. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol Chem 383:1519-1536.
127. Shum L, Coleman CM, Hatakeyama Y, Tuan RS. 2003. Morphogenesis and dysmorphogenesis of the appendicular skeleton. Birth Defects Res C Embryo Today 69:102-122.
128. Smith TG, Sweetman D, Patterson M, et al. 2005. Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite. Development 132:1305-1314.
129. Stanton LA, Sabari S, Sampaio AV, et al. 2004. p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J 378(Pt 1):53-62.
130. Stanton LA, Underhill TM, Beier F. 2003. MAP kinases in chondrocyte differentiation. Dev Biol 263:165175.
131. Strieker S, Fundele R, Vortkamp A, Mundlos S. 2002. Role of Runx genes in chondrocyte differentiation. Dev Biol 245:95-108.
132. Sun X, Mariani FV, Martin GR. 2002. Functions of FGF signalling from the apical ectodermal ridge in limb development. Nature 418:501-508.
133. Sundarrajan M, Boyle DL, Chabaud-Riou M, et al. 2003. Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK. Arthritis Rheum 48:2450-2460.
134. Takahashi K, Nuckolls GH, Takahashi I, et al. 2001. Msx2 is a repressor of chondrogenic differentiation in migratory cranial neural crest cells. Dev Dyn 222:252-262.
135. Taylor SM, Jones PA. 1979. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779.
136. Theodosiou A, Ashworth A. 2002. MAP kinase phosphatases. Genome Biol 3:3009.
137. Tibbles LA, Woodgett JR. 1999. The stress-activated protein kinase pathways. Cell Mol Life Sci 55:12301254.
138. Tuan RS. 2003. Cellular signaling in developmental chondrogenesis: N-cadherin, Wnts, and BMP-2. J Bone Joint Surg Am A 85(Suppl 2):137-141.
139. Tuan RS, Boland G, Tuli R. 2003. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5:32-45.
140. Tufan AC, Daumer KM, DeLise AM, Tuan RS. 2002. AP-1 transcription factor complex is a target of signals from both Wnt-7a and N-cadherin-dependent cell-cell adhesion complex during the regulation of limb mesenchymal chondrogenesis. Exp Cell Res 273:197-203.
141. Tuli R, Tuli S, Nandi S, et al. 2003. Transforming growth factor-β-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem 278:41227-41236.
142. Turjanski AG, Vaque JP, Gutkind JS. 2007. MAP kinases and the control of nuclear events. Oncogene 26:3240-3253.
143. Urness LD, Li C, Wang X, Mansour SL. 2008. Expression of ERK signaling inhibitors Dusp6, Dusp7, and Dusp9 during mouse ear development. Dev Dyn 237:163-169.
144. Wang G, Beier F. 2005. Rac1/Cdc42 and RhoA GTPases antagonistically regulate chondrocyte proliferation, hypertrophy, and apoptosis. J Bone Miner Res 20:1022-1031.
145. Wang H, Wang Z, Chen J, Wu J. 2007. Apoptosis induced by NO via phosphorylation of p38 MAPK that stimulates NF-κB, p53 and caspase-3 activation in rabbit articular chondrocytes. Cell Biol Int 31:1027-1035.
146. Watanabe H, de Caestecker MP, Yamada Y. 2001. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-β-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 276:14466-14473.
147. Weston AD, Chandraratna RA, Torchia J, Underhill TM. 2002. Requirement for RAR-mediated gene repression in skeletal progenitor differentiation. J Cell Biol 158:39-51.
148. Widmann C, Gibson S, Jarpe MB, Johnson GL. 1999. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143-180.
149. Woods A. 2005. Structure, function, and metabolism of cartilage proteoglycans. In: Koopman WJ, Moreland LW, editors. Arthritis and Allied Conditions: A Textbook of Rheumatology.15th ed. Philadelphia, PA: Lippincott Williams & Wilkins. pp. 211-222.
150. Woods A, Beier F. 2006. RhoA/ROCK signaling regulates chondrogenesis in a context-dependent manner. J Biol Chem 281:13134-13140.
151. Yaffe D, Saxel O. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270:725-727.
152. Yagi R, McBurney D, Horton WE Jr. 2005. Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway. J Biol Chem 280:30517-30525.
153. Yasoda A, Komatsu Y, Chusho H, et al. 2004. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10:80-86.
154. Yoon YM, Oh CD, Kim DY, et al. 2000. Epidermal growth factor negatively regulates chondrogenesis of mesenchymal cells by modulating the protein kinase C-α, Erk-1, and p38 MAPK signaling pathways. J Biol Chem 275:12353-12359.
155. Yosimichi G, Kubota S, Nishida T, et al. 2006. Roles of PKC, PI3K and JNK in multiple transduction of CCN2/CTGF signals in chondrocytes. Bone 38:853-863.
156. Zakany R, Szucs K, Bako E, et al. 2002. Protein phosphatase 2A is involved in the regulation of protein kinase A signaling pathway during in vitro chondrogenesis. Exp Cell Res 275:1-8.
157. Zhang R, Murakami S, Coustry F, et al. 2006. Constitutive activation of MKK6 in chondrocytes of transgenic: mice inhibits proliferation and delays endochondral bone formation. Proc: Natl Acad Sci USA 103:365-370.
158. Zhen X, Wei L, Wu Q, et al. 2001. Mitogen-activated protein kinase p38 mediates regulation of chondrocyte differentiation by parathyroid hormone. J Biol Chem 276:4879-4885.
159. Zhou G, Golden T, Aragon IV, Honkanen RE. 2004. Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase I/MKK-4/JNK signaling cascade. J Biol Chem 279:46595-46605.
160. Zou H, Wieser R, Massague J, Niswander L. 1997. Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev 11:2191-2203.
161. Zuzarte-Luis V, Montera JA, RodriguezLeon J, et al. 2004. A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways. Dev Biol 272:39-52.